君实生物(01877)午后涨超10% ,截至发稿,涨9.17%,报26.2港元,成交额4.52亿港元。消息面上,近期,由君实生物自主研发的重组人源化抗PD-1和VEGF双特异性抗体JS207的抗肿瘤作用机制及临床前研究结果在国际知名学术期刊《Frontiers in Immunology》上全文发表,详细描绘了JS207的分子设计、体外特征、功能和临床前抗肿瘤疗效。方正证券指出,JS207(PD1...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.